This type of rosacea may occur alone or with ETR type. Common treatments for PPR include: Ocular rosacea affects your eyes ...

Tarsus Pharmaceuticals, Inc. has announced plans to advance TP-04, an investigational ophthalmic gel formulation of lotilaner, for the treatment of Ocular Rosacea, a significant but currently ...

“My job as a dermatologist is to diagnose and treat the rosacea, uncover any potential comorbidities, and refer back to the primary care giver,” she added. “The last thing that I want to do ...

A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...

Moreover, Tarsus is extending its reach into ocular rosacea, a condition with no FDA-approved treatments, by advancing TP-04 into a Phase 2 study. The potential for TP-04 to address a significant ...

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the donor's immune cells attack the recipient's tissues.

Ocular manifestation of GVHD is among the most challenging to treat, often leading to chronic inflammation and corneal tissue damage, which can result in loss of vision. Conventional treatments ...

The commentary focused on Tarsus Pharmaceuticals' impressive sales figures for their product XDEMVY, particularly highlighting its potential in treating ocular rosacea. The company has ...

Patients may be subject to a variety of different topical medications when undergoing treatment for ocular disease. Preservatives are added to multidose medication bottles to inhibit microbial ...

The commentary focused on Tarsus Pharmaceuticals' impressive sales figures for their product XDEMVY, particularly highlighting its potential in treating ocular rosacea. The company has demonstrated ...